Targeting NSCLC with EGFR mutations, 3rd gen irreversible EGFR-TKI, Active against CNS metastasis, Indicated for EGFR Ex19Del and EGFR L858R mutations,
Sale!
Lucius
Replica Osimertinib: Targeted EGFRm NSCLC Treatment
Original price was: $698.00.$539.00Current price is: $539.00.
Targeting NSCLC with EGFR mutations, 3rd gen irreversible EGFR-TKI, Active against CNS metastasis, Indicated for EGFR Ex19Del and EGFR L858R mutations,